How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
PRINCETON, N.J., June 8 /PRNewswire-FirstCall/ -- Cytogen Corporation(Nasdaq: CYTO) and Royal Philips Electronics (NYSE: PHG; AEX: PHI) today announced the presentation of data demonstrating significantly improved resolution and quality of PROSTASCINT(R) (capromab pendetide) images through the application of Philips' unique Astonish image processing tools. Results were presented at the 53rd Society of Nuclear Medicine (SNM) annual meeting in San Diego , CA on June 5, 2006 .
"The advanced image resolution recovery techniques provided by PROSTASCINT utilizing the Philips Astonish image processing technology allow physicians to visualize in greater detail the location and extent of disease, from both ananatomical and physiological perspective," said Michael Haseman , M.D., Nuclear Medicine physician with Radiological Associates of Sacramento in Sacramento , California one of the authors of the study. "These advances have the potential to simultaneously increase productivity for physicians and benefit patients by decreasing the amount of time for acquisition of a PROSTASCINT image."
Philips offers highly advanced SPECT detector technology, acquisition techniques and reconstruction algorithms, including concurrent imaging, energy independent detector design and Astonish 3-D reconstruction. This patented imaging technology provides exceptional image resolution for single-photonemission computed tomography (SPECT) and novel molecular imaging agents, suchas PROSTASCINT.
"These new technologies create a true breakthrough in terms of SPECT imaging, and we're excited to see clinical improvements being realized atleading hospitals with our products," said Ian Farmer , senior vice president, nuclear medicine, for Philips Medical Systems. "In addition to high quality,high resolution images, the system provides hospitals and research facilities with a competitive advantage for today's procedures and a sound investment forfuture molecular imaging applications."
SNM abstract #1436 titled "PROSTASCINT SPECT image quality is significantly improved by implementation of 3D OSEM with resolution recoveryand attenuation and scatter correction."